My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
VisualScape Inc.
SIBFL
>
City Clerk
>
Bids-RFQ-RFP
>
ITB
>
(24-06-02) Citywide Landscape Maintenance Services
>
Responses
>
VisualScape Inc.
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/5/2024 4:15:45 PM
Creation date
8/5/2024 4:14:41 PM
Metadata
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
217
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Employees who are taking prescription or non-prescription drugs which could affect their ability <br />to perform their job in a safe and efficient manner must notify their immediate manager of this <br />fact. Further, job applicants and employees have the right to confidentially consult the Medical <br />Review Officer (MRO) for technical information regarding prescription and non-prescription <br />medication and may contest or explain the test result to the MRO both before and after being <br />tested. Prior to testing, the job applicant or employee will be given a list of the most common <br />medications by brand name or common name and chemical name which may alter or affect a <br />drug test. This information is also provided on the Drug Testing Chain-of-Custody Form. A Drug <br />Use Information Form, which is a confidential report, may be filled out by job applicants and <br />employees before or after being drug tested. This form permits individuals to provide to the MRO <br />a list of all prescription and non-prescription drugs they are currently using or have used in the <br />last month, as well as any other information they consider relevant to the test. <br /> <br />2.2 Drug and Alcohol Testing Policy <br /> <br />In order to maintain the safety and efficiency of its operations and to protect employees and <br />the public, employees may be required to submit to drug and/or alcohol testing if there is a <br />cause for reasonable suspicion of substance abuse. VisualScape Inc. will select a licensed <br />laboratory which will perform the drug and/or alcohol testing. <br /> <br />The following is a list of some but not all circumstances that could be indicators of a substance <br />abuse problem and considered reasonable suspicion: <br /> <br />(a) Observed alcohol or drug abuse during work hours on Company premises; <br /> <br />(b) apparent physical state of impairment; <br /> <br />(c) incoherent mental state; <br /> <br />(d) marked changes in personal behavior that are otherwise unexplainable; <br /> <br />(e) deteriorating work performance that is not attributable to other factors; and <br /> <br />(f) accidents, on-the-job injuries, or other actions that provide reasonable cause to <br />believe the employee may be under the influence of drugs or alcohol, or that result in <br />off-premises medical attention to the employee, injury to others, or property damage in <br />excess of $250.00. <br /> <br />VisualScape, at its sole discretion, may also conduct follow-up substance testing when an <br />employee enters an employee assistance or rehabilitation program, random or periodic <br />substance testing of all employees, routine testing of job applicants, and routine testing of <br />employees returning to work after a leave of absence of two weeks or more. Employees who <br />refuse substance testing under these circumstances will be terminated. <br /> <br />The type of testing to be conducted includes, but is not limited to, any chemical, biological or <br />physical instrumental analysis, and may require the collection of blood, urine, breath, saliva, or <br />hair of an employee or job applicant. VisualScape Inc. shall test for the following substances: <br /> <br />(a) Alcohol (booze, drink, distilled spirits, wine, malt beverages, beer, intoxicating liquors, <br />alcoholic beverages, etc.); <br /> <br />(b) Amphetamines (Binhetamine, Desoxyn, Dexedrine); <br /> <br />(c) Cannabinoids (marijuana, hashish, hash, hash oil, pot, joint, roach, spleaf, grass, <br />weed, reefer); <br />4 <br /> <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.